Use of spironolactone in dermatology
- PMID: 21413648
Use of spironolactone in dermatology
Abstract
Spironolactone has been used as a potassium-sparing diuretic for more than 30 years. It is a synthetic 17-lactone steroid and primarily acts as an aldosterone antagonist. Since the accidental discovery of its antiandrogenic effects, it has been used in the treatment of many dermatologic conditions in which androgen plays a role in the pathogenesis. Antiandrogenic effects of spironolactone are exerted by reducing testosterone production and inhibiting its action on the target tissues. Spironolactone is used as a primary medical treatment for hirsutism and female pattern hair loss. Continuous treatment is required to sustain the effect. It is an effective alternative treatment for acne in women. It has the benefit of a long-term safety profile. Spironolactone should not be used in pregnancy due to its teratogenic effects and is not used in men due to the risk of feminization.
Similar articles
-
Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.Dermatol Clin. 2010 Jul;28(3):611-8. doi: 10.1016/j.det.2010.03.011. Dermatol Clin. 2010. PMID: 20510769
-
Spironolactone in dermatology: uses in acne and beyond.Clin Exp Dermatol. 2020 Dec;45(8):986-993. doi: 10.1111/ced.14340. Epub 2020 Aug 26. Clin Exp Dermatol. 2020. PMID: 32844462 Review.
-
Antiandrogens in the treatment of acne and hirsutism.Am Fam Physician. 1992 Apr;45(4):1803-6. Am Fam Physician. 1992. PMID: 1532683
-
Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism.Actas Dermosifiliogr (Engl Ed). 2020 Oct;111(8):639-649. doi: 10.1016/j.ad.2020.03.001. Epub 2020 Jun 19. Actas Dermosifiliogr (Engl Ed). 2020. PMID: 32571540 English, Spanish.
-
Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.J Am Acad Dermatol. 2014 Nov;71(5):859.e1-859.e15; quiz 873-4. doi: 10.1016/j.jaad.2014.05.009. Epub 2014 Oct 15. J Am Acad Dermatol. 2014. PMID: 25437978 Review.
Cited by
-
Uterine transplantation in transgender women.BJOG. 2019 Jan;126(2):152-156. doi: 10.1111/1471-0528.15438. Epub 2018 Sep 20. BJOG. 2019. PMID: 30125449 Free PMC article. No abstract available.
-
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study.Prostate Cancer Prostatic Dis. 2020 Sep;23(3):527-533. doi: 10.1038/s41391-020-0220-8. Epub 2020 Mar 2. Prostate Cancer Prostatic Dis. 2020. PMID: 32123316
-
A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair.Nucleic Acids Res. 2014 May;42(9):5689-701. doi: 10.1093/nar/gku217. Epub 2014 Mar 25. Nucleic Acids Res. 2014. PMID: 24682826 Free PMC article.
-
Adult-onset acne: prevalence, impact, and management challenges.Clin Cosmet Investig Dermatol. 2018 Feb 1;11:59-69. doi: 10.2147/CCID.S137794. eCollection 2018. Clin Cosmet Investig Dermatol. 2018. PMID: 29440921 Free PMC article. Review.
-
Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity.JID Innov. 2021 May 6;1(3):100023. doi: 10.1016/j.xjidi.2021.100023. eCollection 2021 Sep. JID Innov. 2021. PMID: 34909723 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical